Don't miss your email and connect your friends with TalkKing!
For many hybridoma-derived antibody projects, sequence identification is an important starting point, but often not the final objective.
After sequencing, projects frequently move toward recombinant antibody redevelopment, sequence confirmation, humanization, or antibody optimization. Coordinating these steps across multiple vendors can slow progress and add unnecessary complexity.
At Synbio Technologies, Hybridoma Sequencing is supported by a broader antibody development workflow designed to help research teams move from hybridoma-derived antibodies to recombinant, sequence-defined formats.
Related workflow support includes:
Hybridoma sequencing & VH/VL identification
Sequence validation and confirmation
Codon optimization
&
gene synthesis
Expression vector construction
Recombinant antibody expression
Antibody humanization
Antibody engineering and optimization
Rather than treating sequencing as a standalone task, a connected workflow can help streamline the transition from hybridoma clone to recombinant antibody while reducing project coordination burden.
Explore Antibody Workflow Solutions
Thank you for connecting with us! Click "
Subscribe
" to receive valuable insights and news. If you prefer not to receive further emails, just hit "
Unsubscribe
" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA